期刊文献+

参麦注射液对急性心肌梗塞大鼠血浆及心肌组织中ANP含量的影响 被引量:5

Effects of Shenmai Injection on ANP in the Blood Plasma and Cardiac Muscle after Acute Myocardial Infarction in Rats
下载PDF
导出
摘要 目的探讨参麦注射液对急性心肌梗塞(AMI)大鼠血浆及心肌组织中心房钠尿肽(ANP)含量的影响。方法通过结扎冠状动脉前降支建立AMI模型大鼠,AMI后24 h存活的48只大鼠随机分为4组:AMI后1周模型组、AMI后参麦注射液治疗1周组、AMI后2周模型组、AMI后参麦注射液治疗2周组。另设1周、2周假手术组各8只。治疗组腹腔注射参麦注射液1次/d,AMI模型组和假手术组大鼠腹腔注射等量的生理盐水。测量各组血浆及心肌组织中ANP含量。结果与假手术组比较,AMI后1周时,血浆及心肌组织中ANP含量明显增高(P<0.01);到梗塞后2周时,虽有所降低,但明显高于模型组,有显著性差异(P<0.01)。参麦注射液治疗组血浆及心肌组织中ANP含量降低,与相应模型组相比差异显著(P<0.05)。结论心肌梗塞后,不论血液循环还是局部心肌组织中ANP都显著性增高,参麦注射液能明显降低ANP的作用。 Objective To evaluate the effects of Shenmai injection on ANP in the blood plasma and cardiac muscle after acute myocardial infarction(AMI) in rats. Methods AMI model was established by ligation of the anterior descending coronary artery in male SD rats. Twenty-four hours after the procedure, the 48 surviving rats were grouped randomly as AMI a week group, AMI two weeks group,Shenmai injection treatment a week and two weeks group (n = 12). A week sham-operated group and two weeks sham - operated group were taken randomly as non - infarction control. A week or two weeks after treatment with the drug and placebo by intraperitoneally(IP) , the ANP in the blood plasma and cardiac muscle was assessed. Results Compared with sham-operated group , ANP in the blood plasma and cardiac muscle increased significantly in AMI group after a week( P 〈 0.01 ) ;ANP decreased in AMI group after two weeks ,but higher than AMI group( P 〈 0.01 ). In comparison with AMI group , ANP decreased significantly in Shenmai injection treatment group after two weeks( P 〈 0.05 ). Conclusion ANP in the blood plasma and cardiac muscle after acute myocardial infarction ( AMI ) in rats increase significantly, ANP decrease significantly in Shenmai injection treatment group.
机构地区 河北北方学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2007年第7期1588-1589,共2页 Lishizhen Medicine and Materia Medica Research
基金 河北省中医药管理局资助项目(No.05019)
关键词 参麦注射液 急性心肌梗塞 心房钠尿肽 Shenmai injection Acute myocardial infarction Atrial natriuretic peptide
  • 相关文献

参考文献9

  • 1Olivetti G,Capasso J M,Meggs LG,et al.Cellular basis of chronic ventricular remodeling after myocardial infarction in mats[J].Circ Res,1991,68:856.
  • 2卜聪亚,陈运贞.大鼠急性心肌梗死后gp130基因异常表达的意义及氯沙坦干预的影响[J].中华心血管病杂志,2004,32(5):446-450. 被引量:5
  • 3Fisbein MC,Melecan D,Marko PR,et al.Experimental myocardial infarctioninthe rats[J].Am J Pathol,1978,90:57.
  • 4Yo shimum M,Yasue H,Ogawa H.Pathophysiological signifi cance and clinical application ofANP and BNP in patients with heart failure[J].Can J PlIy8jol Pharmacol.2001,79:730.
  • 5Langenickel T,Pagel I,Hohnel K,et al.Differential regula tion of cardiac ANP and BNP mRNA in differen tstages of ex perimenta Ihcart failure[J].Am J Physiol HeartCimPhyfid,2000,278:H1500.
  • 6Bademaker MT.Bichards AM.Cardiac natriuretic peptides for cardiac health[J].Cfin Sci(Lond).2004,[Epub ahead of print].
  • 7Tsuneyoshi H,Nishirm T,Nomoto T.Atrial natriuretic peptide helps prevent late remodeling after left vehicular anemysm repmr[J].Circulation.2004,110(Suppl 1):174.
  • 8Hayashi D,Kudoh S,Shiojima let al.Atrial rmtriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1[J].Biochem Biophys Res Commun.2004,322(1):310.
  • 9Gheoghiade M,Ferguson D.Digox in a neurehormonal modula-tot in heart failure[J].Circulation.1991,84:2181.

二级参考文献12

  • 1Takihara K, Kishimoto T. Cytokines and their receptors in cardiovascular diseases-role of gp130 signalling pathway in cardiac myocyte growth and maintenance. Int J Exp Pathol, 2000,81:1-16.
  • 2Pan J, Fukuda K, Kodama H, et al. Involvement of gp130-mediated signalling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels, 1998,13:199-208.
  • 3Fukuzawa J, Booz GW, Hunt RA, et al. Cardiotrophin-1 increases augiotensinogen mRNA in rat cardiac myocyte through STAT3-an autocrine loop for hypertrophy. Hypertension, 2000, 35:1191-1196.
  • 4Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res,1991,68:856-869.
  • 5Weber KT, Janicki JS, Shroft SG, et al. Collagen remodeling of the pressure overload hypertrophied non human primate myocardium. Circ Res, 1998,62:757-765.
  • 6Aoyama T, Takimoto Y, Pennica D, et al. Augmented expression of cardiotrophin-1 and its receptor component gp130 in both left and right ventricules after myocardial infarction in the rat. J Mol Cell Cardiol,2000,32:1821-1830.
  • 7Ju H, Zhao S, Jassal DS, et al. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res,1997,35:223-232.
  • 8Kunisada K, Negoro S, Tone E, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA, 2000,97:315-319.
  • 9Hishinuma S, Funamoto M, Fujio Y, et al. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun,1999,264:436-440.
  • 10Sano M, Fukuda K, Kodama H. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem, 2000, 275: 29717-29723.

共引文献4

同被引文献60

引证文献5

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部